GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Research & Development

Incanthera (AQSE:INC) Research & Development : £0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Incanthera's Research & Development for the six months ended in Mar. 2024 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was £0.00 Mil.


Incanthera Research & Development Historical Data

The historical data trend for Incanthera's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Research & Development Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
- - - - -

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only - - - - -

Incanthera Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incanthera  (AQSE:INC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Incanthera Research & Development Related Terms

Thank you for viewing the detailed overview of Incanthera's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera Headlines